fingolimod

The medicine is used in adults and children and adolescents over 10 years of age for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom other treatments have not worked or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Pharmaselect International Beteiligungs GmbH

The medicine is used in adults for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom previous treatment has not been effective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Pharmathen International S.A.

Fenoxa is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly in patients for whom treatment is not effective or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in adults as well as children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom treatment is ineffective or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AE01

Manufacturer: Coripharma ehf. Genericon Pharma Gesellschaft m.b.H.

This medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in people for whom other treatments have not worked or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Bluepharma Pharmaceutical Industry, S.A.

The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in people for whom treatment is not effective or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Pharmadox Healthcare Ltd.

This medicine is intended for adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in people for whom other treatments have not been effective or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Genepharm S.A.

The medicine is used in adults to treat relapsing forms of multiple sclerosis (MS), particularly in individuals who have not responded to other treatments or in whom the disease is progressing rapidly and severely. It may also be used in children aged 10 years and older. It helps to reduce the number of relapses and slow the progression of disability.

Form: capsules, hard

ATC: L04AA27

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.

The medicine is used in adults as well as children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom other treatments have not been effective or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AE01

Manufacturer: Genepharm S.A.

The medicine is used in adults and children and adolescents (over 10 years of age and weighing more than 40 kg) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom treatment is not effective or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing forms of multiple sclerosis (MS), particularly in individuals for whom other treatments have not worked or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicinal product is used in adults and children and adolescents (over 10 years of age and weighing more than 40 kg) for the treatment of relapsing-remitting multiple sclerosis (MS). It helps to reduce the number of disease relapses and slows the progression of disability.

Form: capsules, hard

ATC: L04AE01

Manufacturer: Labormed-Pharma S.A. S.C. Zentiva S.A.

The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom previous treatment has not been effective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.

Form: capsules, hard

ATC: L04AA27

Manufacturer: neuraxpharm Arzneimittel GmbH, PRASFARMA, S.L.

The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom treatment is not effective or in whom the disease is progressing rapidly and severely.

Form: capsules, hard

ATC: L04AA27

Manufacturer: Novartis Pharma GmbH